FDA

The FDA’s vaccine advisory committee voted in favor of Novavax’s (NVAX) COVID-19 vaccine for use in grownups, paving the way for the corporation to get its initial solution authorized in the U.S. But the working day-lengthy conference lifted a range of worries introduced by Novavax’s late entry to the vaccine […]